Efficacy of pantoprazole plus perforation repair for peptic ulcer and its effect on the stress response

Figure 1 Somatostatin, malondialdehyde and lipid peroxide of patients with peptic ulcer in the two groups. A: Pre- and posttreatment somatostatin levels in the two groups; b: Pre- and posttreatment malondialdehyde levels in the two groups; C: Pre- and posttreatment lipid peroxide levels in the two groups. ^aP < 0.05, ^bP < 0.01. SS: Somatostatin; MDA: Malondialdehyde; LPO: Lipid peroxide.

Figure 2 Tumor necrosis factor-α, C-reactive protein, and interleukin-1β of patients with peptic ulcer in the two groups. A: Pre- and posttreatment tumor necrosis factor-α levels in the two groups; B: Pre- and posttreatment C-reactive protein levels in the two groups; C: Pre- and posttreatment IL-1β levels in the two groups. ^aP < 0.05, ^bP < 0.01. TNF-α: Tumor necrosis factor-α; CRP: C-reactive protein; IL-1β: Interleukin-1β.

Figure 3 Recurrence rate of patients with peptic ulcer in the two groups. ^aP < 0.05.